Jane Street’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $185K | Sell |
19,663
-44,494
| -69% | -$399K | ﹤0.01% | 10181 |
|
|
2026
Q1 | $522K | Sell |
64,157
-453,486
| -88% | -$4.11M | ﹤0.01% | 7955 |
|
|
2025
Q4 | $3.48M | Sell |
517,643
-122,031
| -19% | -$920K | ﹤0.01% | 3803 |
|
|
2025
Q3 | $5.55M | Sell |
639,674
-358,200
| -36% | -$2.79M | ﹤0.01% | 3275 |
|
|
2025
Q2 | $6.29M | Buy |
997,874
+217,389
| +28% | +$1.44M | ﹤0.01% | 2711 |
|
|
2025
Q1 | $5M | Sell |
780,485
-171,432
| -18% | -$1.42M | ﹤0.01% | 2937 |
|
|
2024
Q4 | $7.65M | Sell |
951,917
-886,890
| -48% | -$8.55M | ﹤0.01% | 2153 |
|
|
2024
Q3 | $23.2M | Sell |
1,838,807
-44,730
| -2% | -$578K | 0.01% | 1135 |
|
|
2024
Q2 | $23.8M | Buy |
1,883,537
+1,791,857
| +1,954% | +$18M | 0.01% | 1177 |
|
|
2024
Q1 | $438K | Sell |
91,680
-1,004,825
| -92% | -$4.66M | ﹤0.01% | 6910 |
|
|
2023
Q4 | $5.26M | Buy |
1,096,505
+709,291
| +183% | +$4.34M | ﹤0.01% | 2777 |
|
|
2023
Q3 | $2.8M | Sell |
387,214
-199,101
| -34% | -$1.59M | ﹤0.01% | 3477 |
|
|
2023
Q2 | $4.36M | Sell |
586,315
-2,208
| -0.4% | -$17.4K | ﹤0.01% | 2946 |
|
|
2023
Q1 | $4.08M | Buy |
588,523
+221,801
| +60% | +$2.04M | ﹤0.01% | 2726 |
|
|
2022
Q4 | $3.77M | Buy |
366,722
+299,358
| +444% | +$5.28M | ﹤0.01% | 2875 |
|
|
2022
Q3 | $1.23M | Sell |
67,364
-238,427
| -78% | -$10.3M | ﹤0.01% | 5047 |
|
|
2022
Q2 | $15.7M | Sell |
305,791
-257,407
| -46% | -$13.3M | 0.01% | 1320 |
|
|
2022
Q1 | $41.5M | Sell |
563,198
-86,592
| -13% | -$7.72M | 0.01% | 771 |
|
|
2021
Q4 | $93M | Buy |
649,790
+381,887
| +143% | +$65.6M | 0.03% | 393 |
|
|
2021
Q3 | $55.5M | Sell |
267,903
-154,060
| -37% | -$34M | 0.02% | 566 |
|
|
2021
Q2 | $89.6M | Buy |
421,963
+282,906
| +203% | +$51.8M | 0.04% | 342 |
|
|
2021
Q1 | $25.2M | Buy |
139,057
+57,210
| +70% | +$11.4M | 0.01% | 807 |
|
|
2020
Q4 | $9.13M | Sell |
81,847
-26,124
| -24% | -$2.78M | ﹤0.01% | 1488 |
|
|
2020
Q3 | $11.7M | Sell |
107,971
-106,377
| -50% | -$13M | 0.01% | 1105 |
|
|
2020
Q2 | $17.9M | Buy |
214,348
+185,961
| +655% | +$7.11M | 0.01% | 815 |
|
|
2020
Q1 | $385K | Buy |
+28,387
| New | +$240K | ﹤0.01% | 3938 |
|
|
2019
Q2 | – | Sell |
-16,014
| Closed | -$176K | – | 5558 |
|
|
2019
Q1 | $176K | Buy |
16,014
+563
| +4% | +$17.8K | ﹤0.01% | 4685 |
|
|
2018
Q4 | $569K | Buy |
+15,451
| New | +$599K | ﹤0.01% | 3302 |
|
|
2018
Q2 | – | Sell |
-7,870
| Closed | -$331K | – | 5410 |
|
|
2018
Q1 | $331K | Buy |
7,870
+6,980
| +784% | +$280K | ﹤0.01% | 3913 |
|
|
2017
Q4 | $22K | Sell |
890
-37
| -4% | -$903 | ﹤0.01% | 4469 |
|
|
2017
Q3 | $21K | Buy |
927
+45
| +5% | +$1.01K | ﹤0.01% | 4356 |
|
|
2017
Q2 | $20K | Sell |
882
-43
| -5% | -$844 | ﹤0.01% | 4255 |
|
|
2017
Q1 | $24K | Buy |
+925
| New | +$25.4K | ﹤0.01% | 4035 |
|
|
2016
Q3 | – | Sell |
-2,561
| Closed | -$331K | – | 4361 |
|
|
2016
Q2 | $372K | Buy |
2,561
+1,791
| +233% | +$205K | ﹤0.01% | 3076 |
|
|
2016
Q1 | $80K | Buy |
+770
| New | +$82.6K | ﹤0.01% | 3921 |
|
|
2015
Q4 | – | Sell |
-6,087
| Closed | -$937K | – | 4314 |
|
|
2015
Q3 | $860K | Buy |
6,087
+2,755
| +83% | +$618K | 0.01% | 1762 |
|
|
2015
Q2 | $742K | Buy |
+3,332
| New | +$586K | ﹤0.01% | 1874 |
|
|
2015
Q1 | – | Sell |
-1,088
| Closed | -$177K | – | 3374 |
|
|
2014
Q4 | $129K | Buy |
+1,088
| New | +$114K | ﹤0.01% | 2310 |
|
|
2014
Q3 | – | Sell |
-553
| Closed | -$51K | – | 2899 |
|
|
2014
Q2 | $51K | Buy |
+553
| New | +$48.6K | ﹤0.01% | 2423 |
|
|
2014
Q1 | – | Sell |
-695
| Closed | -$71K | – | 2952 |
|
|
2013
Q4 | $71K | Sell |
695
-3,438
| -83% | -$243K | ﹤0.01% | 2217 |
|
|
2013
Q3 | $261K | Buy |
+4,133
| New | +$233K | ﹤0.01% | 2207 |
|
Other funds holding NVAX
S
Jane Street's NVAX Position: Q2 2026 in Review
Jane Street reduced its Novavax (NVAX) stake by 69% in Q2 2026, selling an estimated $399K and leaving 19,663 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #10181.
Jane Street first reported a position in NVAX in Q3 2013 and has held it in 41 quarters since. The position peaked at $93M in Q4 2021. 247 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Jane Street held 19,663 shares of Novavax worth $185K as of Q2 2026.
- Jane Street sold 44,494 Novavax shares in Q2 2026, an estimated $399K.
- Novavax made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10181 holding.
- Jane Street first reported a position in Novavax in Q3 2013 and has held it in 41 quarters since.
- Jane Street's Novavax position peaked at $93M in Q4 2021.
- 247 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.